Self-testing for cancer: a community survey

Sue Wilson; Angela V. Ryan; Sheila M. Greenfield; Sue C. Clifford; Roger L. Holder; Helen M. Pattison; David A. Fitzmaurice; Richard J. McManus

doi:10.1186/1471-2407-8-102

Self-testing for cancer: a community survey

Sue Wilson, Angela V. Ryan, Sheila M. Greenfield, Sue C. Clifford, Roger L. Holder, Helen M. Pattison, David A. Fitzmaurice, Richard J. McManus

Research output: Contribution to journal › Article › peer-review

Abstract

Background: Cancer-related self-tests are currently available to buy in pharmacies or over the internet, including tests for faecal occult blood, PSA and haematuria. Self-tests have potential benefits (e.g. convenience) but there are also potential harms (e.g. delays in seeking treatment). The extent of cancer-related self-test use in the UK is not known. This study aimed to determine the prevalence of cancer-related self-test use. Methods: Adults (n = 5,545) in the West Midlands were sent a questionnaire that collected socio-demographic information and data regarding previous and potential future use of 18 different self-tests. Prevalence rates were directly standardised to the England population. The postcode based Index of Multiple Deprivation 2004 was used as aproxy measure of deprivation. Results: 2,925 (54%) usable questionnaires were returned. 1.2% (95% CI 0.83% to 1.66%) of responders reported having used a cancer related self test kit and a further 36% reported that they would consider using one in the future. Logistic regression analyses suggest that increasing age, deprivation category and employment status were associated with cancer-related self-test kit use. Conclusion: We conclude that one in 100 of the adult population have used a cancer-related self-test kit and over a third would consider using one in the future. Self-test kit use could alter perceptions of risk, cause psychological morbidity and impact on the demand for healthcare.

Original language	English
Article number	102
Pages (from-to)	102
Journal	BMC Cancer
Volume	8
Issue number	102
DOIs	https://doi.org/10.1186/1471-2407-8-102
Publication status	Published - 14 Apr 2008

Bibliographical note

© 2008 Wilson et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Keywords

Cancer
self-test
faecal occult blood
PSA
haematuria
UK

Access to Document

10.1186/1471-2407-8-102

1471-2407-8-102.pdf
© 2008 Wilson et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Licence: CC BY 3.0

http://www.biomedcentral.com/1471-2407/8/102

Cite this

@article{f3f66e67887a430a8a905751a656492b,

title = "Self-testing for cancer: a community survey",

abstract = "Background: Cancer-related self-tests are currently available to buy in pharmacies or over the internet, including tests for faecal occult blood, PSA and haematuria. Self-tests have potential benefits (e.g. convenience) but there are also potential harms (e.g. delays in seeking treatment). The extent of cancer-related self-test use in the UK is not known. This study aimed to determine the prevalence of cancer-related self-test use. Methods: Adults (n = 5,545) in the West Midlands were sent a questionnaire that collected socio-demographic information and data regarding previous and potential future use of 18 different self-tests. Prevalence rates were directly standardised to the England population. The postcode based Index of Multiple Deprivation 2004 was used as aproxy measure of deprivation. Results: 2,925 (54%) usable questionnaires were returned. 1.2% (95% CI 0.83% to 1.66%) of responders reported having used a cancer related self test kit and a further 36% reported that they would consider using one in the future. Logistic regression analyses suggest that increasing age, deprivation category and employment status were associated with cancer-related self-test kit use. Conclusion: We conclude that one in 100 of the adult population have used a cancer-related self-test kit and over a third would consider using one in the future. Self-test kit use could alter perceptions of risk, cause psychological morbidity and impact on the demand for healthcare.",

keywords = "Cancer, self-test, faecal occult blood, PSA, haematuria, UK",

author = "Sue Wilson and Ryan, {Angela V.} and Greenfield, {Sheila M.} and Clifford, {Sue C.} and Holder, {Roger L.} and Pattison, {Helen M.} and Fitzmaurice, {David A.} and McManus, {Richard J.}",

note = "{\textcopyright} 2008 Wilson et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",

year = "2008",

month = apr,

day = "14",

doi = "10.1186/1471-2407-8-102",

language = "English",

volume = "8",

pages = "102",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "BioMed Central",

number = "102",

}

TY - JOUR

T1 - Self-testing for cancer

T2 - a community survey

AU - Wilson, Sue

AU - Ryan, Angela V.

AU - Greenfield, Sheila M.

AU - Clifford, Sue C.

AU - Holder, Roger L.

AU - Pattison, Helen M.

AU - Fitzmaurice, David A.

AU - McManus, Richard J.

N1 - © 2008 Wilson et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PY - 2008/4/14

Y1 - 2008/4/14

N2 - Background: Cancer-related self-tests are currently available to buy in pharmacies or over the internet, including tests for faecal occult blood, PSA and haematuria. Self-tests have potential benefits (e.g. convenience) but there are also potential harms (e.g. delays in seeking treatment). The extent of cancer-related self-test use in the UK is not known. This study aimed to determine the prevalence of cancer-related self-test use. Methods: Adults (n = 5,545) in the West Midlands were sent a questionnaire that collected socio-demographic information and data regarding previous and potential future use of 18 different self-tests. Prevalence rates were directly standardised to the England population. The postcode based Index of Multiple Deprivation 2004 was used as aproxy measure of deprivation. Results: 2,925 (54%) usable questionnaires were returned. 1.2% (95% CI 0.83% to 1.66%) of responders reported having used a cancer related self test kit and a further 36% reported that they would consider using one in the future. Logistic regression analyses suggest that increasing age, deprivation category and employment status were associated with cancer-related self-test kit use. Conclusion: We conclude that one in 100 of the adult population have used a cancer-related self-test kit and over a third would consider using one in the future. Self-test kit use could alter perceptions of risk, cause psychological morbidity and impact on the demand for healthcare.

AB - Background: Cancer-related self-tests are currently available to buy in pharmacies or over the internet, including tests for faecal occult blood, PSA and haematuria. Self-tests have potential benefits (e.g. convenience) but there are also potential harms (e.g. delays in seeking treatment). The extent of cancer-related self-test use in the UK is not known. This study aimed to determine the prevalence of cancer-related self-test use. Methods: Adults (n = 5,545) in the West Midlands were sent a questionnaire that collected socio-demographic information and data regarding previous and potential future use of 18 different self-tests. Prevalence rates were directly standardised to the England population. The postcode based Index of Multiple Deprivation 2004 was used as aproxy measure of deprivation. Results: 2,925 (54%) usable questionnaires were returned. 1.2% (95% CI 0.83% to 1.66%) of responders reported having used a cancer related self test kit and a further 36% reported that they would consider using one in the future. Logistic regression analyses suggest that increasing age, deprivation category and employment status were associated with cancer-related self-test kit use. Conclusion: We conclude that one in 100 of the adult population have used a cancer-related self-test kit and over a third would consider using one in the future. Self-test kit use could alter perceptions of risk, cause psychological morbidity and impact on the demand for healthcare.

KW - Cancer

KW - self-test

KW - faecal occult blood

KW - PSA

KW - haematuria

KW - UK

UR - http://www.scopus.com/inward/record.url?scp=42649088140&partnerID=8YFLogxK

U2 - 10.1186/1471-2407-8-102

DO - 10.1186/1471-2407-8-102

M3 - Article

C2 - 18410692

SN - 1471-2407

VL - 8

SP - 102

JO - BMC Cancer

JF - BMC Cancer

IS - 102

M1 - 102

ER -

Self-testing for cancer: a community survey

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this